20019AST
Astec® CYCLOBOND I 2000 Chiral (5 μm) HPLC Columns
L × I.D. 15 cm × 2.1 mm, HPLC Column
Synonyme(s) :
CYCLOBOND I 2000 Cyclodextrin-Based Chiral Column
Se connecter pour consulter les tarifs organisationnels et contractuels.
Sélectionner une taille de conditionnement
Changer de vue
A propos de cet article
UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52
L × i.d.:
15 cm × 2.1 mm
Particle size:
5 μm
Matrix active group:
cyclodextrin, beta- phase
Pore size:
100 Å
Matrix:
silica particle platform
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aiderNom du produit
Astec® Cyclobond I 2000 Chiral HPLC Column, 5 μm particle size, L × I.D. 15 cm × 2.1 mm
material
stainless steel column
Quality Segment
product line
Astec®
packaging
pkg of 1 ea
manufacturer/tradename
Astec®
parameter
0-50 °C temperature, 172 bar pressure (2500 psi)
technique(s)
HPLC: suitable, LC/MS: suitable
L × I.D.
15 cm × 2.1 mm
matrix
silica particle platform
matrix active group
cyclodextrin, beta- phase
particle size
5 μm
pore size
100 Å
operating pH
3.5-7
separation technique
chiral
General description
CYCLOBOND I 2000 is bonded with β-cyclodextrin by a patented process to produce a stable matrix with the cyclodextrin arranged in such a way as to retain its most valuable property of forming inclusion complexes. This allows them to effect numerous chemical separations by selectively including into their cavities a wide variety of organic molecules. Non-inclusion type separations are also possible with the polar organic mode for a wide variety of molecule types.
Resources:
CYCLOBOND FAQs
CYCLOBOND Reference Bibliography
Chiral Product Literature
- Bonded phase: Underivatized, native β-cyclodextrin
Resources:
CYCLOBOND FAQs
CYCLOBOND Reference Bibliography
Chiral Product Literature
Application
- Thioether bridged cationic cyclodextrin stationary phases: Effect of spacer length, selector concentration and rim functionalities on the enantioseparation.: This study investigates the effect of different variables on the enantioseparation efficiency of thioether bridged cationic cyclodextrin stationary phases, utilizing the Astec CYCLOBOND 2000 Chiral HPLC Column for the separation processes (Li et al., 2016).
- Enantiomeric separations of illicit drugs and controlled substances using cyclofructan-based (LARIHC) and cyclobond I 2000 RSP HPLC chiral stationary phases.: This research explores the use of cyclobond I 2000 RSP HPLC chiral stationary phases, including Astec CYCLOBOND 2000, in the enantiomeric separation of various illicit drugs and controlled substances (Padivitage et al., 2014).
- Screening approach, optimisation and scale-up for chiral liquid chromatography of cathinones.: The paper discusses a screening approach and optimization methods for chiral liquid chromatography of cathinones, highlighting the application of Astec CYCLOBOND 2000 Chiral HPLC Column in these processes (Perera et al., 2012).
- Stereoselective analysis of hydroxybupropion and application to drug interaction studies.: This study focuses on the stereoselective analysis of hydroxybupropion using chiral stationary phases, including Astec CYCLOBOND 2000, to explore drug interaction effects (Xu et al., 2007).
- Solid-phase extraction of methadone enantiomers and benzodiazepines in biological fluids by two polymeric cartridges for liquid chromatographic analysis.: This research investigates the extraction and analysis of methadone enantiomers and benzodiazepines in biological fluids using the Astec CYCLOBOND 2000 Chiral HPLC Column for effective separation (He et al., 2005).
Legal Information
Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under Astec® Cyclobond I 2000 Chiral HPLC Column
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.